...
首页> 外文期刊>Bone marrow transplantation >Successful early unmanipulated haploidentical transplantation with reduced-intensity conditioning for primary graft failure after cord blood transplantation in hematologic malignancy patients
【24h】

Successful early unmanipulated haploidentical transplantation with reduced-intensity conditioning for primary graft failure after cord blood transplantation in hematologic malignancy patients

机译:血液系统恶性肿瘤患者成功进行早期早期未操纵单倍体移植并降低强度调节以治疗脐血移植后的原发性移植失败

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Primary graft failure (pGF) is a frequent complication following cord blood transplantation (CBT). For those patients who will not experience autologous recovery, salvage transplantation should be performed as early as possible. However, standardized treatment protocols for pGF, such as the optimal stem cell source, preparative regimen and the ideal time for salvage transplantation, have yet to be determined. Therefore, we analyzed 17 hematologic malignancy patients who received unmanipulated haploidentical peripheral blood (PB) and BM transplantation with reduced-intensity conditioning (RIC) as a salvage therapy for pGF after CBT. The median interval between the two transplantations was 38 days. The RIC regimen for salvage transplantation consisted of fludarabine, antithymocyte globulin, CY and low-dose TBI. The neutrophil and plt engraftments were achieved in 14 (82.4%) and 13 (76.4%) patients, respectively. The cumulative incidences of grades II-IV and grades III-IV aGVHD were 35.3% and 17.6%, respectively. The cumulative incidence of chronic GVHD was 29.4%. After a median follow-up of 43 months, 10 of 17 patients remained alive in CR. The cumulative incidence of TRM at 180 days was 29.4%. The probability of 3-year OS and leukemia-free survival was 57.5%. Our results show that unmanipulated haploidentical PB and BM transplantation under a RIC regimen is an effective treatment for pGF after CBT.
机译:原发性移植物衰竭(pGF)是脐带血移植(CBT)后的常见并发症。对于不会自体恢复的患者,应尽早进行抢救移植。然而,尚未确定用于pGF的标准化治疗方案,例如最佳干细胞来源,制备方案和抢救移植的理想时间。因此,我们分析了17例血液系统恶性肿瘤患者,这些患者接受了未经操纵的单倍体外周血(PB)和BM移植和降低强度调节(RIC)作为CBT后pGF的挽救疗法。两次移植之间的中位间隔为38天。抢救移植的RIC方案包括氟达拉滨,抗胸腺细胞球蛋白,CY和小剂量TBI。中性粒细胞和plt植入分别实现了14(82.4%)和13(76.4%)位患者。 II-IV级和III-IV级aGVHD的累积发生率分别为35.3%和17.6%。慢性GVHD的累积发生率为29.4%。在中位随访43个月后,17例患者中有10例仍然存活。 180天TRM的累积发生率为29.4%。 3年OS和无白血病生存的可能性为57.5%。我们的结果表明,在RIC方案下未经操纵的单倍体PB和BM移植是CBT后pGF的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号